subota, 05.11.2011.
BIOTECH INVESTMENT FUNDS : INVESTMENT FUNDS
BIOTECH INVESTMENT FUNDS : DEFINITION OF INVESTMENT RISK.
Biotech Investment Funds
- investment: money that is invested with an expectation of profit
- (Investment fund) A collective investment scheme is a way of investing money with others to participate in a wider range of investments than feasible for most individual investors, and to share the costs and benefits of doing so.
- (Investment fund) A term generally interchangeable with "mutual fund."
- Genetically modified
- biotechnology: the branch of molecular biology that studies the use of microorganisms to perform specific industrial processes; "biotechnology produced genetically altered bacteria that solved the problem"
- Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. Modern use similar term includes genetic engineering as well as cell- and tissue culture technologies.
Welcome to Biotech Nation: My Unexpected Odyssey into the Land of Small Molecules, Lean Genes, and Big Ideas
As host of public radio’s Tech Nation, Dr. Moira Gunn has long been known for making all aspects of science and technology meaningful to the general listening public. But when she spontaneously decided at a cocktail-fueled biotech industry event that she would be launching a weekly segment on biotech -- a subject that existed well outside of her normal comfort zone -- she had her work cut out for her. For the millions of people who now listen to BioTech Nation, the rest is history.
Going behind the science and business of biotech, the book rides along with Dr. Gunn as she interviews an interesting and colorful cast of characters from the industry, including a DNA scientist with ego to burn and a pharmaceutical exec with a penchant for Viagra. Filled with compelling stories of everything from the genetically modified food fight to the reasons why the presidential stem lines are dying, the book explores the fascinating theories and breakthroughs in this exciting field.
Funny, entertaining, and informative, Welcome to BioTech Nation is a unique, inside look at biotechnology today...and a glimpse at what could be in store for us tomorrow.
As host of public radio’s Tech Nation, Dr. Moira Gunn has long been known for making all aspects of science and technology meaningful to the general listening public. But when she spontaneously decided at a cocktail-fueled biotech industry event that she would be launching a weekly segment on biotech -- a subject that existed well outside of her normal comfort zone -- she had her work cut out for her. For the millions of people who now listen to BioTech Nation, the rest is history.
Going behind the science and business of biotech, the book rides along with Dr. Gunn as she interviews an interesting and colorful cast of characters from the industry, including a DNA scientist with ego to burn and a pharmaceutical exec with a penchant for Viagra. Filled with compelling stories of everything from the genetically modified food fight to the reasons why the presidential stem lines are dying, the book explores the fascinating theories and breakthroughs in this exciting field.
Funny, entertaining, and informative, Welcome to BioTech Nation is a unique, inside look at biotechnology today...and a glimpse at what could be in store for us tomorrow.
78% (
5)
Biotech CE Dialyis Trial Kits - 1 m/roll
Ideal for small volume dialysis or evaluation of membrane for an application, biotech grade Cellulose Ester (CE) tubing is now available in 1 m length trial kits with a pair of tubing closures.
Product Specifications
Kit Includes:1 m roll of Biotech CE dialysis tubing
2 Unviersal Closures
5 opening picks
biotech! is godzilla! - lensbabies-
this shot reminded me of an old Godzilla movie..Biolanta! and one of my Favorites sepultura songs Biotech! is godzilla!
biotech investment funds
Why has the biotechnology industry failed to perform up to expectations - despite all its promise? In "Science Business", Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear s for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter - term 'monetisation' of intellectual property. Pisano maintains that all industry players - biotech firms, investors, universities, pharmaceutical companies, government regulators - can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being.
See also:
investment money
investment group ratings
technology investment partners llc
the sound investment band
what do investment firms do
annuity a good investment
fiscal policy investment
05.11.2011. u 13:45 •
0
Komentara •
Print •
#